56 results
8-K
EX-99.1
GRTS
Gritstone Bio Inc
8 Nov 23
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
4:06pm
participant, randomized Phase 2b double-blinded study to compare the efficacy, safety, and immunogenicity of Gritstone’s samRNA vaccine candidate
8-K
EX-99.1
1xq4ez
27 Sep 23
Entry into a Material Definitive Agreement
4:07pm
8-K
wnftcpxyv
15 Aug 23
Other Events
7:21am
8-K
EX-10.1
0rtxu1035lmzgkcyoct0
25 Oct 22
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-99.1
zgmoso9dobz
25 Oct 22
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-99.1
88ksj5rds eqhe89pb71
4 Jan 22
Other Events
5:21pm
8-K
EX-99.2
tnmej4xw
4 Jan 22
Other Events
5:21pm